OACP
OaCP provides patented and CE-IVD chemical reagents that reduce times (-97%) and costs (-50%) of DNA tests for cancer diagnosis. OaCP addresses the Molecular in vitro diagnostics market, starting from the high competitive USD 1b In situ Hybridization one, reaching USD 100K in sales with 100% of CRR and 98% of GM to hospitals and R&D centres. OaCP takes advantage also from a distribution network that covers almost 15 countries globally. Driven by a team with complementary skills in Science, Busin... ess, Marketing and Web communication, OaCP undergone to the RebelBio Accelerator program in 2017, receiving, up to today, USD330k in funding mainly from SOS Venture. OaCP has been awarded in several international competition mainly in Hong Kong and China. Now OaCP is looking for an investment on Euro 2M to push, expand and consolidate the market presence, to create a company able to grow organically to bring to the greatest number of cancer patients the best diagnostic technology.
OACP
Industry:
Health Care Health Diagnostics
Founded:
2017-07-07
Address:
Cork, Cork, Ireland
Country:
Ireland
Website Url:
http://www.oncology-and-cytogenetic-products.com
Total Employee:
1+
Status:
Active
Contact:
+393200745878
Total Funding:
328.1 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Mobile Non Scaleable Content Sitelinks Search Box Organization Schema
Similar Organizations
Metabolomic Diagnostics
Metabolomic Diagnostics specializes in the development of novel biomarker based diagnostic solutions for complex diseases
xRapid
xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence.
Current Advisors List
Advisor
2017-04-04
Advisor
2017-05-01
Advisor
2017-03-27
Advisor
2017-03-27
Current Employees Featured
Enrico Di Oto CEO @ OaCP
CEO
2017-03-27
Andrea Faviere CMO @ OaCP
CMO
2017-03-27
Matteo Allegro CCO @ OaCP
CCO
2017-03-27
Simone Di Giacomo R&D Manager @ OaCP
R&D Manager
2021-01-01
Founder
Investors List
Official Site Inspections
http://www.oncology-and-cytogenetic-products.com
- Host name: plesklin5.if1.ehiweb.it
- IP address: 79.98.45.12
- Location: Poggio Renatico Italy
- Latitude: 44.7658
- Longitude: 11.487
- Timezone: Europe/Rome
- Postal: 44028
More informations about "OaCP"
Fast Laboratory Diagnostics - OaCP
OaCP IE LTD (Oncology and Cytogenetic Products) is a company that was conceived in 2015 as a project within the Bologna University Entrepreneurship Program called Launch Pad. “We …See details»
OaCP - Crunchbase Company Profile & Funding
OaCP provides patented and CE-IVD chemical reagents that reduce times (-97%) and costs (-50%) of DNA tests for cancer diagnosis. OaCP addresses the Molecular in vitro diagnostics …See details»
Oncology and Cytogenetic Products
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a …See details»
Oncology And Cytogenetic Products - Company Profile - Tracxn
Nov 18, 2024 Developer of chemical and biotechnological products for fast diagnosis in oncology. The company develops a range of in situ hybridization reagents for the detection of …See details»
OACP - EmiliaRomagnaStartUp
OaCP Srl (Oncology and Cytogenetic Products) is a company that operates in the field of Advanced Diagnostics and Research in various fields: biomedical, biotechnological, …See details»
OaCP Company Profile - Office Locations, Competitors, Revenue
OaCP (Oncology and Cytogenetic Products) is a company that provides oncology diagnostics laboratories and research institutions with FISH (fluorescence in situ hybridization) solutions. It …See details»
Oncology And Cytogenetic Products - Raised Funding from 5
Oct 11, 2024 Oncology And Cytogenetic Products has raised funding over 1 round from 5 investors. Investors include SOSV, Capital Venture Consulting and 3 others. Their latest …See details»
Guiding the global evolution of cytogenetic testing for …
Apr 14, 2022 Genomic characterization has become an essential component in the clinical management of hematologic malignancies, supporting diagnosis and prognostication as well …See details»
Oncology And Cytogenetic Products | Competitors - Tracxn
May 26, 2023 Details about top competitor companies of Oncology And Cytogenetic ProductsSee details»
Cytogenetics Testing - ARUP Laboratories
Oncology Cytogenetics. Proven Quality We are certified by the Children’s Oncology Group (COG), which demonstrates our high caliber of excellence and quality in oncology cases. Hematologic Malignancies and Solid Tumor Cases. …See details»
Cytogenetics Lecture 1: Introduction to Clinical Cytogenetics
Indications for Cytogenetic Analysis (Constitutional) •Postnatal, childhood growth and development –Perinatal/newborn: Birth defects, malformations, dysmorphisms, ambiguous …See details»
Oncology and Cytogenetic Products News
Mar 15, 2021 News of OaCP Srl, Oncology and Cytogenetic Products. March 15, 2021. One of the main concerns related to the pandemic response politics is the spread of SARS-CoV-2 …See details»
New Data from PROMMIS Study Highlights the Power of SKY92 in ...
9 hours ago SkylineDx, an innovative diagnostics company specializing in the research and development of molecular diagnostics for oncology, inflammatory, and infectious diseases, …See details»
Atlas of Genetics and Cytogenetics in Oncology and Haematology, …
Jan 1, 2001 This is our contribution to the network. Reciprocally, we are referenced/hyperlinked by Human Genome Organization (HUGO), National Cancer Institute (CancerNet), International …See details»
Atlas of Genetics and Cytogenetics in Oncology and Haematology
The Atlas of Genetics and Cytogenetics in Oncology and Haematology gives reviews on genes involved in cancer, leukemias, solid tumors, and cancer-prone diseases. It also provides …See details»
Rapid CoViD-19 Antigen Test - OaCP - oncology-and-cytogenetic …
LoD: 1.5×102 TCID50 for virus lysate, 10pg/mL for recombinant Nucleocapsid protein antigen.. Compared with NAT method, the specimens with the Ct range up to 35 will be detectable.. …See details»
Health Rounds: Experimental CG Oncology immunotherapy shows …
1 day ago An experimental immunotherapy drug is a potentially effective treatment for patients with bladder cancer who no longer respond to current therapies, researchers reported on …See details»
Guiding the global evolution of cytogenetic testing for ... - PubMed
Apr 14, 2022 With recent publications highlighting novel sequencing technologies as alternatives to conventional cytogenetic approaches, we, an international consortium of laboratory …See details»
New Data from PROMMIS Study Highlights the Power of SKY92 in ...
1 day ago ROTTERDAM (the Netherlands), SAN DIEGO (CA, USA), December 7, 2024—SkylineDx, an innovative diagnostics company specializing in the research and …See details»